RPL39P33

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, RPL39P33 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RPL39P33’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RPL39P33 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL39P33 is over-expressed in tumor.

STAD and THCA are the cancer types where RPL39P33 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL39P33 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
STADFemaleAll+0.375.0012view →
THCAAllIII,IV+0.200.0272view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RPL39P33–STAD

Tumor-vs-normal expression box plot for RPL39P33 RNA in STAD.

Open the STAD breakdown →

Exploration